Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

European shares flat, weighed on by financials

Published 06/16/2009, 05:16 AM
Updated 06/16/2009, 05:24 AM

* FTSEurofirst 300 up 0.1 percent

* Financials weigh on index; pharmas up

* Macro data eyed later in the day

* For up-to-the-minute market news, click on

By Christoph Steitz

FRANKFURT, June 16 (Reuters) - European shares ticked higher on Tuesday morning with the leading index weighed on by financials, and after the previous session's steep losses.

At 0915 GMT, the FTSEurofirst 300 index of top European shares was up 0.1 percent at 863.86 points, after having been up as much as 0.3 percent earlier in the session.

"The questions is now whether the market correction will continue," said Heino Ruland, market strategist at Ruland Research in Germany, noting the heavy losses on Wall Street on Monday and, to some extent, in Asia earlier on Tuesday.

U.S. stocks fell on Monday after regional manufacturing data dented optimism about the economy's health and resource shares fell alongside commodity prices.

Banks and insurers were the heaviest losers, with BNP Paribas, UniCredit and Allianz down 2.1-3.6 percent.

The European Central Bank had said on Monday that euro area insurance companies may face "significant" balance sheet stress ahead due to financial market turbulence and a weak economy.

It also said euro zone banks faced potential further writedowns of $283 billion through 2010.

Around Europe, Britain's FTSE 100 index was up 0.5 percent, Germany's DAX index was flat and France's CAC 40 was up 0.2 percent.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

PHARMAS GAIN, MACRO DATA EYED

Pharma stocks added most points to the pan-European index, and the DJ STOXX European health care index was up 0.8 percent.

German Bayer rose 0.6 percent after its chief executive told a newspaper that debt reduction and securing liquidity was taking precedence over acquisitions during the economic crisis.

Sanofi-Aventis and GlaxoSmithKline rose 2.3 percent and 1.8 percent respectively.

Shares in Britain's biggest retailer Tesco rose 2.5 percent, after the company reported its best quarterly sales rise in Britain for two years.

British consumer price inflation slowed less than anticipated in May, staying above the Bank of England's 2 percent target.

Investors will also look out for more macro data from the United States later in the day, with U.S. building permits due 1230 GMT, and industrial production due 1315 GMT.

"If housing permits and starts give reason to hope that the U.S. housing market correction is running out, the recovery of Bunds and U.S. Treasuries will start to falter. However, we do not assume it is already about to end," Commerzbank wrote in a note.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.